DURECT Corporation Appoints Matthew J. Hogan As Chief Financial Officer

September 12, 2006 |

1 min read

CUPERTINO, Calif., Sept. 12 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX - News), an emerging specialty pharmaceuticals company, announced today that Matthew J. Hogan has joined the Company as Chief Financial Officer.

People

MORE ON THIS TOPIC

Business handshake trendy halftone art collage banner template. Partnership concept, successful agreement, closing a deal, securing a contract. Modern retro cut out vector illustration

Mergers & acquisitions

Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly

April 29, 2026

·

2 min read

·

Gabrielle Masson

Shanghai,China-August 24th 2025: AstraZeneca company office building

Earnings

AstraZeneca bullish on $80B sales goal after beating expectations, Phase 3 data wins

April 29, 2026

·

2 min read

·

Nick Paul Taylor

Conceptual origami paper plane pulling business finance growth chart line flying upwards on blue sky background.

Earnings

GSK’s Shingrix strategy shift drives sales beat even as vaccines slow

April 29, 2026

·

2 min read

·

Tristan Manalac

Recovering losses, effective economic measures to help alleviate inflation or economic crisis resulting in the collapse of the business economy or stock market, helping hands to catch gold coins rolling down a tilted cliff

Patents

Pfizer settles with generic drugmakers to protect blockbuster drug until 2031

April 29, 2026

·

2 min read

·

Nick Paul Taylor